2022
medRxiv (2022). 10.1101/2022.03.24.22272864.
2022
Vaccine, (2022).40 47 10.1016/j.vaccine.2022.09.049.
Safety of the Ad26.ZEBOV/MVA-BN-Filo vaccine regimen in adults, children and pregnant women in DRC and immunogenicity of a delayed 2nd dose: the DRC-EB-001 trial.
2022
(2022).
2022
Science (New York, N.Y.), (2022).375 6587 10.1126/science.abo1980.
2022
medRxiv (2022). 10.1101/2022.06.06.22276026.
2022
Parasite Immunology, (2022).44 9 10.1111/pim.12939.
2022
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2022).116, 10.1016/j.ijid.2022.01.025.
2022
(2022). 10.17037/PUBS.04665244.
2022
medRxiv (2022). 10.1101/2022.06.14.22276391.